Pfizer Independent Medical Education Grant Request for Proposals: Advancing Genomic Competence and Patient Centered Care in Metastatic Breast Cancer
This Pfizer grant funds programs to enhance genomic understanding and patient-centered communication skills among healthcare professionals in metastatic breast cancer care.
Funder: Pfizer Inc.
Due Dates: July 20, 2026 (Submission deadline)
Funding Amounts: Up to $100,000 per project (smaller requests encouraged); max project length 18 months; up to 10 awards expected
Summary: Supports independent educational programs to improve genomic competence and patient-centered communication among healthcare professionals in metastatic breast cancer care.
Key Information: Applications must be submitted by 23:59 Eastern Standard Time on the deadline; only organizations, not individuals, are eligible.
Description
This grant opportunity from Pfizer aims to support integrated educational programs that enhance genomic competence and patient-centered communication skills among healthcare professionals (HCPs) involved in the care of patients with metastatic breast cancer (mBC). The focus is on developing curricula, case-based learning, and communication training to improve the understanding and interpretation of genomic testing and to equip clinicians to engage patients in shared decision-making. Projects should address both technical genomic knowledge and patient-centered communication, using innovative, unbranded educational resources such as conversation guides, decision aids, and virtual tumor boards.
